Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of hV01 in Advanced Pancreatic Cancer
CTR20252005Phase 2Active
- Sponsor
- Hangzhou ConVerd Co., Ltd.
- Start
- Oct 2025
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CVD-1301.V01 in pancreatic cancer (PC), sponsored by Hangzhou ConVerd Co., Ltd.. Started Oct 2025; status: active.
02
Drugs
CVD-1301.V01
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on CTR20252005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252005.